Skip to main content
OpenTrials

Clinical trial condition

Abnormalities, Multiple

Explore clinical trials studying Abnormalities, Multiple. Study availability and eligibility vary by location and protocol.

1,105 public trials 246 recruiting studies
Refine in advanced search Browse all conditions

Abnormalities, Multiple trial results

Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

NCT07228364

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Loma Linda, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

NCT07280585

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +11 more
Locations
  • Vorarlberger Krankenhaus-Betriebsgesellschaft Feldkirch, Austria
  • Medizinische Universitaet Innsbruck Innsbruck, Austria
  • Robert Bosch Gesellschaft für Medizinische Forschung mbH Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum Nürnberg Nuremberg, Bavaria, Germany
View all 30 locations
View Trial Details
Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

NCT06714006

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street, Southport, Gold Coast, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
View Trial Details
Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions
22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations
  • Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada
  • University of Alberta-Glenrose Edmonton, Alberta, Canada
  • Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Recruiting

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

NCT07157254

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +7 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Clinical Trial Site Baltimore, Maryland, United States
  • Clinical Trial Site Kansas City, Missouri, United States
View all 21 locations
View Trial Details
Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

NCT07405164

Conditions
Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +11 more
Locations
  • Beth Israel Deaconess Medical Center ( Site 0107) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute ( Site 0105) Boston, Massachusetts, United States
  • Karmanos Cancer Center ( Site 0108) Detroit, Michigan, United States
  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100) Philadelphia, Pennsylvania, United States
View all 49 locations
View Trial Details

Related conditions